LXRP - Lexaria Bioscience announces addition to its patent portfolio

Lexaria Bioscience (LXRP) has been granted U.S. Patent No. 10,756,180, entitled "Food and Beverage Compositions Infused With Lipophilic Active Agents and Methods of Use Thereof".This new patent provides patent claims that protect the use of Lexaria's DehydraTECH technology together with cannabinoids, nicotine, nonsteroidal anti-inflammatory drugs, or vitamins in mix and serve beverage formats. The company currently has 17 granted patents, with 9 granted in the US and 8 in Australia, along with roughly 60 patent applications pending throughout the world.

For further details see:

Lexaria Bioscience announces addition to its patent portfolio